Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: Hepatitis Delt a Virus (HDV) antigen is widely used as a capture antigen in ELISAs for the identification of HDV infection; large amounts of recombinant HDV antigen with active antigenicity are required for this purpose.
Methods: Reconstruct the gene of HDV antigen based on the bias code of Escherichia coli, the recombinant protein expresses by high-density fermentation with fed-batch feeding strategy, and purify by immobilized metal chromatography. The sensitivity and specificity of this antigen detect by ELISA method.
Results: The expression of HDV antigen can reach 20% of the total cell mass in the soluble form. The recombinant HDV antigen can be conveniently purified (98%) by immobilized metal ion affinity chromatography (IMAC) using the interaction between a His-tag and nickel ions. Production of recombinant HDV antigen can reach 0.5 g/L under conditions of high-density cell fermentation. Applied to the diagnostic ELISA method, the recombinant HDV antigen shows excellent sensitivity (97% for IgM and 100% for IgG) and specificity (100% for IgG and IgM) for the detection of anti-HDV antibodies.
Conclusion: Expression and purification the recombinant HDV antigen as a candidate protein for application in a diagnostic ELISA for HDV infection. Large-scale production of the protein can be achieved using the high-density fermentation strategy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3967/bes2016.054 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ubiquitinated hepatitis D antigen-induced CD8 T-cell responses inhibit HDV replication in HDV-infected liver organoids.
Antiviral Res
September 2025
Department of Infection, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
Background: Hepatitis D virus (HDV) infection is the most severe form of human viral hepatitis. A poor virus-specific CD8T cell response may result in persistent HDV infection. We investigated anti-viral effect and mechanisms of ubiquitinated small hepatitis D antigen (Ub-S-HDAg) in HBV/HDV superinfected liver organoids.
View Article and Find Full Text PDFEngineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.
J Hepatol
August 2025
Vir Biotechnology, Bellinzona, Switzerland. Electronic address:
Background & Aims: Effective immune targeting is likely essential for achieving functional cure of chronic hepatitis B (CHB). Tobevibart, a human monoclonal antibody against hepatitis B virus (HBV) surface antigen (HBsAg), neutralizes HBV and hepatitis delta virus (HDV). This study aimed to characterize effects of the engineered GAALIE Fc of tobevibart on HBV immune responses.
View Article and Find Full Text PDF[Introduction of the key update points of the 2025 Canadian Association for the Study of the Liver guideline for the management of chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
August 2025
Peking University Health Science Center, Beijing 100191, China.
The Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada developed jointly the 2025 guidelines for the management of chronic hepatitis B in May 2025. The guidelines updated recommendations for universal adult HBV screening, vaccination, laboratory assessment, treatment, patient-centered care, early diagnosis, expanding antiviral treatment. Notably, the guidelines recommend reflex HDV testing and routine use of quantitative HBsAg for the decision of HBV management.
View Article and Find Full Text PDFClinical impact of hepatitis delta virus coinfection on liver fibrosis in hepatitis B patients: a population-based study.
Virol J
August 2025
Department of Epidemiology and Biostatistics, Indiana University Bloomington, Bloomington, IN, USA.
Background: Evaluation of liver fibrosis appears to be easily overlooked in the clinic for the chronic Hepatitis D. Herein, we determine the Clinical Impact of liver fibrosis among HBsAg-positive/Anti-HDV positive US general adults.
Methods: Data were obtained from the National Health and Nutrition Examination Survey (NHANES) 1999-2020.
Novel Implementation of Hepatitis B to Hepatitis Delta Reflex Testing in a US Healthcare System.
Am J Gastroenterol
July 2025
Department of Gastroenterology & Hepatology, Weill Cornell Medicine, New York, New York, USA.
Introduction: Hepatitis delta virus (HDV) is the most aggressive form of viral hepatitis, yet screening rates in the United States are low, and few institutions have attempted interventions to improve the screening cascade. We assessed barriers to reflex test implementation, including lack of a Food and Drug Administration-approved reflex test, and implemented hepatitis B surface antigen (HBsAg) to HDV antibody (HDV Ab) reflex testing in our large, urban, academic healthcare system.
Methods: We evaluated outcomes 1 year after implementation using summary statistics.